US$ 21.02
obesity drug news today glp-1 2025 sep 30 Pharma Giants Bet on Next-Generation Treatments to Sustain Growth Obesity Week 2025 Medications
Description
Clinical studies provide strong evidence of their benefits

One important nuance: hunger often starts creeping back before the drug has fully cleared, because the effects fade as blood levels fall

First global approval
The science is rather elegant: protein stimulates the release of incretin hormones, including our star player GLP-1, which then works its magic on blood sugar regulation

Some people try to buy 6 months or a year of supply to reduce trip frequency
Teva Announces FDA Approval and Launch of Generic Saxenda (liraglutide injection) First Generic GLP-1 Indicated for Weight Loss
